{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:25:13Z","timestamp":1794273913129,"version":"4.9.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002570","name":"American Association of Immunologists Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002570","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.omtn.2026.102885","type":"journal-article","created":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T07:09:19Z","timestamp":1773558559000},"page":"102885","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cytolysis limits IFN-I and effector memory CD8 T cells after viral vector vaccination"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9986-4906","authenticated-orcid":false,"given":"Pablo","family":"Penaloza-MacMaster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2026.102885_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2026.102852","article-title":"Non-cytolytic re-engineering of a viral vaccine vector enables durable effector-memory T cell immunity by reinforcing type I IFN induction","volume":"37","author":"Ciancaglini","year":"2026","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.102885_bib2","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S1097-2765(00)00120-9","article-title":"Vesicular stomatitis virus matrix protein inhibits host cell gene expression by targeting the nucleoporin Nup98","volume":"6","author":"von Kobbe","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtn.2026.102885_bib3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.molcel.2004.11.023","article-title":"VSV disrupts the Rae1\/mrnp41 mRNA nuclear export pathway","volume":"17","author":"Faria","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtn.2026.102885_bib4","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1126\/science.1235208","article-title":"Blockade of chronic type I interferon signaling to control persistent LCMV infection","volume":"340","author":"Wilson","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.102885_bib5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1126\/science.1235214","article-title":"Persistent LCMV infection is controlled by blockade of type I interferon signaling","volume":"340","author":"Teijaro","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.102885_bib6","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aah6817","article-title":"Interferon-driven deletion of antiviral B cells at the onset of chronic infection","volume":"1","author":"Fallet","year":"2016","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.omtn.2026.102885_bib7","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191220","article-title":"Early type I IFN blockade improves the efficacy of viral vaccines","volume":"217","author":"Palacio","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.omtn.2026.102885_bib8","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/imm.12771","article-title":"Regulation of CD4 T cells and their effects on immunopathological inflammation following viral infection","volume":"152","author":"Bhattacharyya","year":"2017","journal-title":"Immunology"},{"key":"10.1016\/j.omtn.2026.102885_bib9","doi-asserted-by":"crossref","DOI":"10.1172\/JCI192371","article-title":"Type I IFN-dependent FcgammaRIV signaling in murine monocytes promotes lethal anaphylaxis during viral infections","volume":"136","author":"Elwy","year":"2026","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtn.2026.102885_bib10","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1016\/j.ymthe.2025.08.037","article-title":"Orf virus-based vectors induce potent germinal center B cell, Tfh cell, and CD8(+) T cell responses","volume":"33","author":"Kastner","year":"2025","journal-title":"Mol. Ther."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126000569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126000569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:16:29Z","timestamp":1794273389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253126000569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2162253126000569"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2026.102885","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytolysis limits IFN-I and effector memory CD8 T cells after viral vector vaccination","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2026.102885","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102885"}}